Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity

Immunization with Escherichia coli Outer Membrane Vesicles Protects Bacteria-Induced Lethality via Th1 and Th17 Cell Responses

(2013) O. Y. Kim et al.   JOURNAL OF IMMUNOLOGY

Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses

(2012) M.-R. Kim et al.   ALLERGY

Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials

(2012) Fabio Bagnoli et al.   Frontiers in Cellular and Infection Microbiology

Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses

(2011) Hwan Keun Kim et al.   FASEB JOURNAL

Development of a vaccine against Staphylococcus aureus

(2011) Brad Spellberg et al.   Seminars in Immunopathology

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

(2011) Clayton D. Harro et al.   VACCINE

Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation

(2010) S.-W. Hong et al.   ALLERGY

Cooperation of TLR2 with MyD88, PI3K, and Rac1 in Lipoteichoic Acid–Induced cPLA2/COX-2–Dependent Airway Inflammatory Responses

(2010) I-Ta Lee et al.   AMERICAN JOURNAL OF PATHOLOGY

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic

(2010) M. Z. David et al.   CLINICAL MICROBIOLOGY REVIEWS

Novel targeted immunotherapy approaches for staphylococcal infection

(2010) Michael Otto   EXPERT OPINION ON BIOLOGICAL THERAPY

Staphylococcus aureuscapsule type 8 antibodies provide inconsistent efficacy in murine Models of staphylococcal infection

(2010) James Cook et al.   Human vaccines & immunotherapeutics

Influenza vaccine immunology

(2010) Philip R. Dormitzer et al.   IMMUNOLOGICAL REVIEWS

Peptidoglycan enhances proinflammatory cytokine expression through the TLR2 receptor, MyD88, phosphatidylinositol 3-kinase/AKT and NF-kappaB pathways in BV-2 microglia

(2010) Hsiao-Yun Lin et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Immunotherapeutic strategies to combat staphylococcal infections

(2010) Knut Ohlsen et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice

(2010) John S. Cho et al.   JOURNAL OF CLINICAL INVESTIGATION

Outer Membrane Vesicles Derived from Escherichia coli Induce Systemic Inflammatory Response Syndrome

(2010) Kyong-Su Park et al.   PLoS One

Proteome analysis of outer membrane vesicles from a clinicalAcinetobacter baumanniiisolate

(2009) Sang-Oh Kwon et al.   FEMS MICROBIOLOGY LETTERS

Anti-Staphylococcal Humoral Immune Response in Persistent Nasal Carriers and Noncarriers ofStaphylococcus aureus

(2009) Nelianne J. Verkaik et al.   JOURNAL OF INFECTIOUS DISEASES

MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)

(2009) Barbara C. Baudner et al.   PHARMACEUTICAL RESEARCH

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

(2009) G. Galli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gram-positive bacteria produce membrane vesicles: Proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles

(2009) Eun-Young Lee et al.   PROTEOMICS

Long-Distance Delivery of Bacterial Virulence Factors by Pseudomonas aeruginosa Outer Membrane Vesicles

(2009) Jennifer M. Bomberger et al.   PLoS Pathogens

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

(2009) Lin Lin et al.   PLoS Pathogens

Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice

(2008) L. P. N. Tuchscherr et al.   INFECTION AND IMMUNITY

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

(2008) B. Spellberg et al.   INFECTION AND IMMUNITY

Vaccination and passive immunisation against Staphylococcus aureus

(2008) Adam C. Schaffer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Vaccination with Clumping Factor A and Fibronectin Binding Protein A to PreventStaphylococcus aureusInfection of an Aortic Patch in Mice

(2008) Carlos Arrecubieta et al.   JOURNAL OF INFECTIOUS DISEASES

Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant

(2008) Arun T. Kamath et al.   PLoS One